Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer (Q35150445)

6 August 2017

1 reference

title

Carcinogenesis and cyclooxygenase: the potential role of COX-2 inhibition in upper aerodigestive tract cancer (English)

1 reference

6 August 2017

1 reference

Sivani Mohan

1

1 reference

6 August 2017

Joel B Epstein

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

39

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

537-546

1 reference

The epidemiology of tongue cancer: a review of global incidence.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Cancer of the tongue in patients younger than 40 years. A distinct entity?

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

The influence of alcohol consumption on worldwide trends in mortality from upper aerodigestive tract cancers in men

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Prostaglandin synthase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Colorectal cancer and nonsteroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Correlation of expression of cyclooxygenase-2, vascular endothelial growth factor, and peroxisome proliferator-activated receptor delta with head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Cyclooxygenases: structural, cellular, and molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-Iiodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active Site

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Adenomatous polyposis coli, protein kinases, protein tyrosine phosphatase: the effect of sulindac

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Further studies on the therapeutic effect of indomethacin on esophageal tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Aspirin use and incidence of large-bowel cancer in a California retirement community

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Decreased expression of bcl-2 in moderate and severe oral epithelia dysplasias

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Inhibition of cyclooxygenase-2 gene expression by p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Host cyclooxygenase-2 modulates carcinoma growth.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Molecular characterization of angiogenic properties of human oral squamous cell carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

VEGF in the culture of PMN and the serum in oral cavity cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Hypoxic induction of HIF-1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Prostaglandin H synthase and xenobiotic oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Benzo[a]pyrene up-regulates cyclooxygenase-2 gene expression in oral epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Inhibition of cyclooxygenase-2: an approach to preventing cancer of the upper aerodigestive tract

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Inhibition of cyclooxygenase-2 expression. An approach to preventing head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Prostaglandins in squamous cell carcinoma of the head and neck: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Inhibitory effects of non-steroidal anti-inflammatory drugs, piroxicam and indomethacin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male ACI/N rats

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Delay in hamster buccal pouch carcinogenesis by aspirin and indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Prostaglandins in carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Specific inhibition of cyclooxygenase-2 results in inhibition of proliferation of oral cancer cell lines via suppression of prostaglandin E2 production

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Quantitation of epidermal growth factor receptor gene amplification by competitive polymerase chain reaction in pre-malignant and malignant oral epithelial lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

13-cis-retinoic acid in the treatment of oral leukoplakia

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Anticancer activity and mechanism of action of retinoids in oral and pharyngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Topical application of vitamin A to oral leukoplakia: A clinical case series

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

The effect of retinoids on premalignant oral lesions: focus on topical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Aspirin use, cancer, and polyps of the large bowel

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Aspirin use and lung, colon, and breast cancer incidence in a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Aspirin use and reduced risk of fatal colon cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Nonsteroidal antiinflammatory drugs and colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: structure-activity relationship

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Antiangiogenic and chemopreventive activities of celecoxib in oral carcinoma cell

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Regression of Head and Neck Carcinoma With a Prostaglandin-Synthesis Inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Targeting angiogenic processes by combination rofecoxib and ionizing radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Inhibitor of cyclooxygenase-2 induces cell-cycle arrest in the epithelial cancer cell line via up-regulation of cyclin dependent kinase inhibitor p21

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

PPARgamma-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

COX-2 expression in dysplasia of the head and neck: correlation with elF4E

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

The potential of molecular screening.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Inhibition of head and neck tumor cell growth with arachidonic acid metabolism inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2803%2900035-6

7 January 2021

10.1016/S1368-8375(03)00035-6

Identifiers

DOI

1 reference

6 August 2017

1 reference